Caladan Bio Inc. — Form D
Caladan Bio Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2024-02-13. The offering totals $5.1M, of which $5.1M was reported sold. Industry: Other Technology.
Offering
- Filed: 2024-02-13
- Form: D
- Accession: 0001062993-24-002895
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $5.1M
- Amount sold: $5.1M
- Investors: 7
- Date of first sale: 2024-02-02
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-505078
Issuer
- Name: Caladan Bio Inc.
- CIK: 0002011857
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 27 W 16TH STREET UNIT 5D, NEW YORK, NY, 10011
- Phone: 847-370-1228
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Robert J Jauquet | Director | Jersey City, NJ |
| Michael J Kobida | Director | New York, NY |
| Robert J Jauquet | Executive Officer | Jersey City, NJ |
| Michael J Kobida | Executive Officer | New York, NY |
More